A charity boss who once tipped the scales at more than 28st says weight-loss injections have changed the way he thinks about ...

The U.S. Food and Drug Administration ordered a hold on a study of an early-stage obesity drug being developed by Amgen, another potential setback in the company’s efforts to join the booming weight ...

The international consulting firm Clarivate makes its bet among the novelties ready for the medicine cabinet this year: three ...

GLP-1 drugs mimic a hormone that sends the brain signals of fullness. Researchers theorize that the drugs could work the same ...

New research suggests that Ozempic and similar weight loss medications have the potential to be as big a game changer in ...

Finally, a few studies in mice have found that the medications can reduce the buildup of the protein tau in the brain, which is a key contributor to Alzheimer’s disease. Scaling back tau buildup could ...

The condition appears to be triggered when the optic nerve swells, choking off its blood supply because the nerve's pathway ...

Robert F. Kennedy Jr. sounded concern on the GRAS process and claimed GLP-1s are “miracle drugs” but fell short on the drugs ...

Approximately 15.5 million Americans have been or currently are on injectable diabetes or weight-loss medications known as ...

Use precise geolocation data and actively scan device characteristics for identification. This is done to store and access ...

Surgical patients may still have leftovers in their system even after a standard fast, potentially increasing the chance of a ...

Wegovy is a GLP-1 agonist containing semaglutide, the same active ingredient as Ozempic. While both medications share this ...